Table 1 Clinicopathologic characteristics and GOLPH3 expression of patients with clinically N0 oral tongue cancer of the study cohort (n = 179)
Characteristics | Number of cases (%) |
|---|---|
Gender | |
Male | 109 (60.9) |
Female | 70 (39.1) |
Age (years) | |
< 53 | 89 (49.7) |
≥ 53 | 90 (50.3) |
Pathologic stage | |
I | 80 (44.7) |
II | 67 (37.4) |
III | 17 (9.5) |
IV | 15 (8.4) |
T classification | |
T1 | 87 (48.6) |
T2 | 87 (48.6) |
T3 | 5 (2.8) |
N classification | |
N0 | 149 (83.2) |
N1 | 15 (8.4) |
N2 | 15 (8.4) |
Nodal status | |
N0 | 149 (83.2) |
N + (N1 and N2) | 30 (16.8) |
Pathologic differentiation | |
Well | 136 (76.0) |
Moderately | 36 (20.1) |
Poorly | 7 (3.9) |
Recurrence | |
No | 123 (68.7) |
Yes | 56 (31.3) |
Vital status (at follow-up) | |
Alive | 131 (73.2) |
Dead | 48 (26.8) |
Expression of GOLPH3 | |
Low or none expression | 57 (31.8) |
High expression | 122 (68.2) |